Kenvue
- Company typePublic
- Founded2022
- HeadquartersSkillman, United States
- Headcount5,001–10,000
- GTM typeB2C
- OfferingHardware or Manufacturing
Kenvue firmographics
Firmographics- Name
- Kenvue
- Legal name
- Kenvue Inc.
- Website
- https://kenvue.com
- Company type
- Public
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
Kenvue industry classification
Industry- Product category
- Consumer Health Products
- NAICS
- Other Health and Personal Care Retailers (45619)
- SIC
- Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where Kenvue is headquartered
LocationHeadquarters
- HQ city
- Skillman
- HQ country
- United States
- HQ region
- North America
Offices15 records
Markets served
Kenvue business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D, Infrastructure
Revenue model
- Self Care (OTC Medicines): Over-the-counter medicines including Tylenol, Motrin, Benadryl, Zyrtec, and Nicorette generating revenue through retail pharmacy and consumer purchases. Segment reported 1.9% growth in Q1 2026.
- Skin Health and Beauty: Skincare and beauty products including Neutrogena, Aveeno, OGX, and Rogaine. Segment led performance with 8.4% net sales growth in Q1 2026, supported by innovations including Neutrogena Sun Care expansion.
- Essential Health: Essential health products including Listerine, Band-Aid, Johnson's Baby, and Imodium. Segment grew 4.9% in Q1 2026.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Quarterly | Dividend Aristocrat with 63 consecutive years of dividend increases |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Kenvue product offering
Product offeringCore offering
Kenvue is the world's largest pure-play consumer health company, manufacturing and marketing a portfolio of iconic over-the-counter medicines, skincare, oral care, baby care, and personal health brands. The company operates across three segments — Self Care (Tylenol, Motrin, Benadryl, Zyrtec, Nicorette, Imodium), Skin Health and Beauty (Neutrogena, Aveeno, OGX, Rogaine), and Essential Health (Listerine, Band-Aid, Johnson's Baby) — distributing products to approximately 1.2 billion consumers across more than 165 countries through retail pharmacies, drugstores, and e-commerce channels.
Product overview
Kenvue is the world's largest pure-play consumer health company, operating as a multi-brand portfolio organized across three segments: Self Care (over-the-counter medicines like Tylenol, Benadryl, Zyrtec, Sudafed, Nicorette, and Imodium), Skin Health and Beauty (Neutrogena, Aveeno, OGX, Rogaine, Clean & Clear, and Zarbees), and Essential Health (Band-Aid, Johnson's Baby, and Calpol). The company markets Listerine for oral care and Benylin for cold symptoms. Brands are distributed globally across retail and e-commerce channels, backed by clinical research and healthcare professional endorsements. Founded in 2022 and spun off from Johnson & Johnson in 2023, Kenvue touches the lives of approximately 1.2 billion consumers across over 165 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Listerine: Oral care mouthwash brand; alcohol-based antiseptic product for reducing plaque and freshening breath.
- Neutrogena
- Aveeno
- Band-Aid
- Tylenol
- Johnson's Baby
- Zyrtec
- OGX
- Rogaine
- Nicorette
- Benadryl
- Le Petit Marseillais
- Imodium
- Sudafed
- Benylin
- Calpol
- Nicorette
- Zarbees
- Clean & Clear
Products and services
- Tylenol
Quantifiable outcome
- 8.4% net sales growth in Skin Health and Beauty segment Q1 2026
- +4 more outcomes
Companies that use Kenvue
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Kenvue technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability9 records
Feature6 records
Kenvue partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor and core.
- Fuel TransportminorPilot program called Electric Loop (eLoop) testing electric freight delivery across select urban routes in Greater Toronto Area. Electric truck deployment on short-haul routes evaluating real-world operational performance, energy efficiency, and emissions impact in dense city conditions.
- Asia Pacific Dental FederationminorKenvue (makers of LISTERINE) supported landmark white paper on evidence-based daily oral self-care guidelines. Report highlights brushing reaches only 25% of mouth surfaces; therapeutic mouthwash reduces plaque by 25-50% and gum bleeding by up to 67.8%.
- GreyparrotcoreStrategic collaboration leveraging Greyparrot's Deepnest AI platform to analyze and validate packaging performance in real-world recycling facilities in UK and US. Moves beyond theoretical design-for-recycling to actual recovery data, enabling packaging circularity improvements and EPR cost forecasting.
- MicrosoftcoreMulti-year collaboration to modernize digital and data capabilities, aligning dermatologist education, AI-driven insights, and e-commerce execution to support Kenvue's innovation strategy.
- Population Services International IndiaminorCollaboration on World Hand Hygiene Day and 'No Fear of Diarrhoea' initiative in Kanpur district, India. Health Department partnership distributing ORS packets and demonstrating proper handwashing techniques.
- CVS Media Exchange (CMX)coreRetail media partnership where Kenvue leverages CVS's CorIQ AI platform for media planning, real-time optimization, and measurement. Kenvue achieved 30% or greater lift in buyer conversion and basket size through the partnership.
- Essex Bio-Technology LimitedminorCollaboration with Kenvue for consumer health products, announced alongside Essex's strategic partnerships for distribution including Beifushu entering Singapore market and MOU with Suzhou Industrial Park for life sciences accelerator.
- Mayo CliniccoreThree-year research collaboration with Aveeno brand focusing on skin health science including preclinical and clinical investigations on skin longevity and regeneration. Builds on 80-year history of collaboration dating to 1945 when Musher brothers worked with Mayo Clinic to develop colloidal oatmeal treatments.
- Kimberly-Clark CorporationcoreKimberly-Clark announced plans to acquire Kenvue for approximately $48.7 billion enterprise value, creating a combined entity with ~$32 billion in revenue and $7 billion EBITDA pre-synergies. Deal approved by shareholders in January 2026 with CCI approval in India; expected to close H2 2026. Kenvue shareholders to receive $3.50 per share plus 0.14625 Kimberly-Clark shares per share.
- Sonoma PharmaceuticalsminorManufacturing and Supply Agreement for Microcyn technology-based products in US, effective October 2025 through March 2027 with potential extensions. Sonoma also launching new dermatology products and burn relief hydrogel in US retail stores.
Scale indicators16 records
Recent moves7 records
Expansion highlights5 records
Kenvue competitors and assessment
Company assessmentDirect peers
- Church & Dwight: Church & Dwight (NYSE: CHD) operates in personal care, household, and specialty consumer health with brands including Orajel (oral pain relief competing with Anbesol/Tylenol Oral), Batiste (dry shampoo), and Trojan. The diversified consumer health orientation and North American retail distribution model align closely with Kenvue's approach.
- Reckitt Benckiser: Reckitt (LSE: RKT) operates a Health segment (Mucinex, Delsym, Nurofen, Gaviscon) that directly competes with Kenvue's OTC franchise, plus Hygiene (Lysol, Dettol) and Home care. Reckitt is one of the closest pure-play comparables to Kenvue's OTC + hygiene orientation with similar pharmacy channel distribution.
- L'Oréal: L'Oréal (EPA: OR) is the world's largest beauty company with dermatological brands (CeraVe, La Roche-Posay, Vichy) directly competing with Kenvue's Neutrogena and Aveeno franchises. The Skin Health and Beauty segment faces its most formidable competitor in L'Oréal's Active Cosmetics division, which has captured significant clinical skincare share.
- Estée Lauder: Estée Lauder (NYSE: EL) operates premium skincare and beauty brands (Estée Lauder, Clinique, La Mer) competing with Kenvue's Neutrogena in mass-to-prestige skincare. While more premium-focused, Estée Lauder's dermatological skincare investments and global beauty distribution create direct competitive pressure on Kenvue's Skin Health and Beauty growth.
- Haleon: Haleon (NYSE: HLN) is the world's other major pure-play consumer health company, spun off from GSK in 2022. It directly competes with Kenvue across OTC (Advil vs Tylenol, Centrum vs Flintstones), oral health (Sensodyne vs Listerine adjacent categories), and respiratory health (Panadol, Voltaren). Both companies share the same pure-play consumer health DNA, pharmacy distribution model, and brand-driven growth strategy.
- Beiersdorf: Beiersdorf (XETRA: BEI) is a global skincare leader with Nivea, Eucerin, La Prairie, and Hansaplast directly competing with Kenvue's Neutrogena, Aveeno, and Band-Aid franchises. The dermatological positioning, OTC adjacency (Eucerin), and global skincare scale make Beiersdorf a direct peer in Skin Health and Beauty and wound care.
- Bayer Consumer Health: Bayer's Consumer Health division (part of XETRA: BAYN) includes Aspirin, Claritin, Aleve, and Coppertone (now sold to Kenvue-aligned brands), directly competing with Kenvue's pain relief, allergy, and sun care franchises. The portfolio overlap in OTC analgesics and sun protection makes Bayer Consumer Health a direct comparable.
- Colgate-Palmolive: Colgate-Palmolive (NYSE: CL) is the global oral care leader (Colgate, Tom's of Maine, meridol) directly competing with Kenvue's Listerine franchise, plus personal care (Palmolive, Softsoap) overlapping with Kenvue's body care brands. The business model alignment and shared retail channels make Colgate one of Kenvue's most direct competitors.
Broad incumbents
- Procter & Gamble: P&G (NYSE: PG) is a diversified CPG incumbent with overlapping brands including Vicks (OTC cold), Pepto-Bismol (digestive), Align (probiotics), Oral-B (oral care), and Gillette (personal care). While P&G is much broader than Kenvue, the consumer health portfolio competes directly across most of Kenvue's Self Care and Essential Health segments.
- Johnson & Johnson: Johnson & Johnson (NYSE: JNJ) was Kenvue's parent company until the May 2023 spin-off and continues to operate in adjacent consumer health-adjacent categories through its pharma and medtech segments. While J&J divested its consumer health business, the historical parent relationship, overlapping R&D heritage, and ongoing competitive dynamics make J&J a relevant broad incumbent comparable.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Kenvue social profiles
Digital presenceKenvue financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kenvue leadership team
Management profileNumber of profiles
Profiles13 records
Kenvue subsidiaries and ownership
Company hierarchySubsidiaries12 records
Kenvue funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kenvue M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kenvue
What does Kenvue do?
Kenvue is the world's largest pure-play consumer health company, manufacturing and marketing a portfolio of iconic over-the-counter medicines, skincare, oral care, baby care, and personal health brands. The company operates across three segments — Self Care (Tylenol, Motrin, Benadryl, Zyrtec, Nicorette, Imodium), Skin Health and Beauty (Neutrogena, Aveeno, OGX, Rogaine), and Essential Health (Listerine, Band-Aid, Johnson's Baby) — distributing products to approximately 1.2 billion consumers across more than 165 countries through retail pharmacies, drugstores, and e-commerce channels.
Is Kenvue a public or private company?
Kenvue is a public company. It is classified as public and is currently operating.
When was Kenvue founded?
Kenvue was founded in 2022. It employs 5,001 to 10,000 people.
Where is Kenvue based?
Kenvue is headquartered in Skillman, United States, in the North America region.
How does Kenvue make money?
Three revenue lines are on record. Self Care (OTC Medicines) is the primary driver. The others are skin Health and Beauty and essential Health.
Who are Kenvue's main competitors?
Direct peers on record are Church & Dwight, Reckitt Benckiser, L'Oréal, Estée Lauder, Haleon, Beiersdorf, Bayer Consumer Health and Colgate-Palmolive. Broad incumbents are Procter & Gamble and Johnson & Johnson.
Does Kenvue have an API?
No public API is recorded for Kenvue.
What industry is Kenvue in?
Kenvue's product category is Consumer Health Products. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 45619 and its SIC code is 2834.